About the Esthesioneuroblastoma Session
Esthesioneuroblastoma, a rare type of cancer, arises from the olfactory epithelium in the nasal cavity. Research on esthesioneuroblastoma focuses on understanding its genetic and molecular characteristics to develop targeted therapies. Scientists are exploring novel treatment approaches such as immunotherapy and precision medicine to improve patient outcomes. Additionally, advancements in imaging techniques aid in early detection and accurate staging of the disease, enabling timely intervention. Collaborative efforts among oncologists, geneticists, and bioinformaticians are essential to unravel the complexities of esthesioneuroblastoma and devise personalized treatment strategies. Despite its rarity, ongoing research endeavors strive to enhance our understanding of this malignancy and pave the way for more effective therapies, offering hope to individuals affected by esthesioneuroblastoma.
Topics Covered in Esthesioneuroblastoma
Olfactory Epithelium Origin
Histologic Grading
Neuroendocrine Markers
Endoscopic Resection
Adjuvant Radiotherapy
Neck Node Management
Related Scientific Sessions at CIOC 2027
Why Attend the Esthesioneuroblastoma Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Esthesioneuroblastoma work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Esthesioneuroblastoma research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Esthesioneuroblastoma track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Esthesioneuroblastoma Conference 2027 — FAQs
What is the Esthesioneuroblastoma track at CIOC 2027?
The Esthesioneuroblastoma track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Esthesioneuroblastoma. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Esthesioneuroblastoma sessions?
Cancer researchers and clinicians, educators and students with an interest in Esthesioneuroblastoma are all welcome — whether presenting or attending.
Can I present my research in the Esthesioneuroblastoma track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Esthesioneuroblastoma sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Esthesioneuroblastoma track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
